Aave founder Stani Kulechov says a user confirmed a warning to proceed with the swap, despite “extraordinary slippage,” while a MEV bot also attacked the large transaction.
Latest NewsRead More
You might also be interested in reading Celldex slides after Barzolvolimab hits target but fails to improve EoE symptoms in phase 2 trial.